An international multicenter observational non-interventional prospective study of the efficacy of azilsartan medoxomil in overweight or obese patients with arterial hypertension (CONSTANT)-Reference-Cited by-同舟云学术

An international multicenter observational non-interventional prospective study of the efficacy of azilsartan medoxomil in overweight or obese patients with arterial hypertension (CONSTANT)

Published:2020-12-07 Issue:2 Volume:37 Page:185-193
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Chazova Irina E.¹,Zhernakova Yulia V.¹^ORCID

Affiliation:

1. Ministry of Health of the Russian Federation, Federal State Budget Institution National Medical Research Center of Cardiology, Moscow, Russian Federation

Funder

Takeda

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1844647

Reference23 articles.

1. Undiagnosed obesity in hypertension: Clinical and therapeutic implications

2. Obesity and cardiovascular risk

3. Inadequate Control of Hypertension in US Adults With Cardiovascular Disease Comorbidities in 2003-2004

4. Overweight and Obesity as Determinants of Cardiovascular Risk

5. Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of azilsartan medoxomil in the treatment of hypertension: a systematic review and meta-analysis;Frontiers in Cardiovascular Medicine;2024-07-04

2. Optimization of blood pressure control in patients with resistant arterial hypertension and visceral obesity;Consilium Medicum;2022-12-15